Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study.
| Image |  |
|---|---|
| Description | scientific article published on 28 March 2018 |
| Author/s |
author: Ryusei Matsuyama |
| Publication date | March 28, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |